{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:19:23Z","timestamp":1783160363227,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016573","name":"Japan Association for Diabetes Education and Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Physiological Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jphyss.2026.100079","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:43:41Z","timestamp":1778816621000},"page":"100079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db\/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activity"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2546-0700","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-8512","authenticated-orcid":false,"given":"Wanxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-7229","authenticated-orcid":false,"given":"Dauren","family":"Zhantleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yermek","family":"Rakhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazymgul","family":"Kulzhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7834-4440","authenticated-orcid":false,"given":"Abilkhair","family":"Yussupov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-0285","authenticated-orcid":false,"given":"Masanori","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-2652","authenticated-orcid":false,"given":"Toshihiko","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphyss.2026.100079_bib1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s13300-019-0657-8","article-title":"SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice","volume":"10","author":"Ali","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jphyss.2026.100079_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13300-019-00747-3","article-title":"Renal outcomes in Type 2 Diabetes: a review of cardiovascular and renal outcome trials","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jphyss.2026.100079_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2011.560181","article-title":"A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials","volume":"44","author":"Musso","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.jphyss.2026.100079_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jphyss.2026.100079_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/dc08-1863","article-title":"Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes","volume":"32","author":"List","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphyss.2026.100079_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/obr.12841","article-title":"Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities","volume":"20","author":"Brown","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.jphyss.2026.100079_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40265-019-1057-0","article-title":"Emerging role of SGLT-2 inhibitors for the treatment of obesity","volume":"79","author":"Pereira","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jphyss.2026.100079_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy balance after sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphyss.2026.100079_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13098-017-0297-y","article-title":"Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center","volume":"9","author":"Thewjitcharoen","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jphyss.2026.100079_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eat.20740","article-title":"Prospectively predicting dietary restraint: the role of interpersonal self-efficacy, weight\/shape self-efficacy, and interpersonal stress","volume":"43","author":"Cain","year":"2010","journal-title":"Int J. Eat Disord"},{"key":"10.1016\/j.jphyss.2026.100079_bib11","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41598-025-86419-8","article-title":"Association between cognitive restraint, emotional eating, uncontrolled eating, and body mass index among health care professionals","volume":"15","author":"Alqahtani","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphyss.2026.100079_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1146\/annurev-psych-010418-102936","article-title":"Stress and Obesity","volume":"70","author":"Tomiyama","year":"2019","journal-title":"Annu Rev Psychol."},{"key":"10.1016\/j.jphyss.2026.100079_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1467-789X.2005.00166.x","article-title":"A review of psychosocial pre-treatment predictors of weight control","volume":"6","author":"Teixeira","year":"2005","journal-title":"Obes Rev"},{"key":"10.1016\/j.jphyss.2026.100079_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1185\/03007995.2015.1082991","article-title":"Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials","volume":"31","author":"Blonde","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jphyss.2026.100079_bib15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2024.27402","article-title":"Age and sex differences in efficacy of treatments for Type 2 Diabetes: a network meta-analysis","volume":"333","author":"Hanlon","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jphyss.2026.100079_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40001-025-03759-x","article-title":"Sex-consistent outcomes in SGLT2 inhibitor-treated acute myocardial infarction patients: a real-world study","volume":"31","author":"Guo","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jphyss.2026.100079_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bdd.2040","article-title":"Physiologically based pharmacokinetic-pharmacodynamic modeling to predict concentrations and actions of sodium-dependent glucose transporter 2 inhibitor canagliflozin in human intestines and renal tubules","volume":"37","author":"Mori","year":"2016","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jphyss.2026.100079_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.114.217992","article-title":"Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats","volume":"351","author":"Kuriyama","year":"2014","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.jphyss.2026.100079_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/db21-0934","article-title":"Canagliflozin prevents hyperglycemia-associated muscle extracellular matrix accumulation and improves the adaptive response to aerobic exercise","volume":"71","author":"MacDonald","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.jphyss.2026.100079_bib20","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.2147\/DMSO.S269916","article-title":"Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism","volume":"13","author":"Kawarasaki","year":"2020","journal-title":"Diab Metab Syndr Obes"},{"key":"10.1016\/j.jphyss.2026.100079_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67024-7","article-title":"A novel methodology utilizing microchip implants to monitor individual activity and body temperature for assessing knee pain in group-housed rats","volume":"14","author":"Hasegawa","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphyss.2026.100079_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1538\/expanim.18-0097","article-title":"Continuous measurement of locomotor activity during convalescence and acclimation in group-housed rats","volume":"68","author":"Yoshizawa","year":"2019","journal-title":"Exp Anim"},{"key":"10.1016\/j.jphyss.2026.100079_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137960","article-title":"Risperidone suppresses caffeine-induced hyperthermia and hyperactivity in rats","volume":"840","author":"Takano","year":"2024","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphyss.2026.100079_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/23328940.2020.1743605","article-title":"Circadian rhythmicity of body temperature and metabolism","volume":"7","author":"Refinetti","year":"2020","journal-title":"Temperature"},{"key":"10.1016\/j.jphyss.2026.100079_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-981-97-4584-5_12","article-title":"Circadian clock and body temperature","volume":"1461","author":"Miyake","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jphyss.2026.100079_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jdn.10189","article-title":"Effects of prenatal exposure to fluoxetine on circadian rhythmicity in the locomotor activity and neuropeptide Y and 5-HT expression in male and female adult Wistar rats","volume":"82","author":"Linhares","year":"2022","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.jphyss.2026.100079_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112320","article-title":"SGLT2 inhibitor canagliflozin reduces visceral adipose tissue in db\/db mice by modulating AMPK\/KLF4 signaling and regulating mitochondrial dynamics to induce browning","volume":"592","author":"Qu","year":"2024","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jphyss.2026.100079_bib28","article-title":"Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jphyss.2026.100079_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/met.2010.0090","article-title":"Set-point theory and obesity","volume":"9","author":"Farias","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jphyss.2026.100079_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.008698","article-title":"Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity","volume":"4","author":"Speakman","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jphyss.2026.100079_bib31","doi-asserted-by":"crossref","first-page":"R1207","DOI":"10.1152\/ajpregu.00109.2011","article-title":"Central circuitries for body temperature regulation and fever","volume":"301","author":"Nakamura","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jphyss.2026.100079_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2021.102918","article-title":"Central sympathetic network for thermoregulatory responses to psychological stress","volume":"237","author":"Nakamura","year":"2022","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jphyss.2026.100079_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1139\/apnm-2018-0310","article-title":"A new conceptual framework for the integrated neural control of locomotor and sympathetic function: implications for exercise after spinal cord injury","volume":"43","author":"Cowley","year":"2018","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jphyss.2026.100079_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.969345","article-title":"Role of sympathetic pathway in light-phase time-restricted feeding-induced blood pressure circadian rhythm alteration","volume":"9","author":"Hou","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.jphyss.2026.100079_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101224","article-title":"SGLT2 inhibitors and the autonomic nervous system in diabetes: a promising challenge to better understand multiple target improvement","volume":"47","author":"Spallone","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jphyss.2026.100079_bib36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/1440-1681.12725","article-title":"Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats","volume":"44","author":"Rahman","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jphyss.2026.100079_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12106-y","article-title":"Time-dependent effects of ipragliflozin on behaviour and energy homeostasis in normal and type 2 diabetic rats: continuous glucose telemetry analysis","volume":"7","author":"Iuchi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphyss.2026.100079_bib38","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00462.2017","article-title":"Leptin regulation of core body temperature involves mechanisms independent of the thyroid axis","volume":"315","author":"Deem","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jphyss.2026.100079_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126445","article-title":"Impaired leptin signalling in obesity: is leptin a new thermolipokine?","volume":"22","author":"Genchi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphyss.2026.100079_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1210\/endrev\/bnz016","article-title":"Leptin: is it thermogenic?","volume":"41","author":"Fischer","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jphyss.2026.100079_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.peptides.2011.01.028","article-title":"Time-dependent effects of leptin on food intake and locomotor activity in goldfish","volume":"32","author":"Vivas","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.jphyss.2026.100079_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023364","article-title":"Contrasting effects of leptin on food anticipatory and total locomotor activity","volume":"6","author":"Ribeiro","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jphyss.2026.100079_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.soard.2011.07.009","article-title":"Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy","volume":"7","author":"Lee","year":"2011","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jphyss.2026.100079_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1726-4901(10)70048-4","article-title":"Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans","volume":"73","author":"Chen","year":"2010","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jphyss.2026.100079_bib45","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.87.21.8642","article-title":"Molecular mapping of the mouse db mutation","volume":"87","author":"Bahary","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jphyss.2026.100079_bib46","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jphyss.2026.100079_bib47","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/oby.21653","article-title":"How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake","volume":"24","author":"Polidori","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.jphyss.2026.100079_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s13679-017-0273-8","article-title":"Weight loss and appetite control in women","volume":"6","author":"Hintze","year":"2017","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.jphyss.2026.100079_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in Type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jphyss.2026.100079_bib50","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"}],"container-title":["The Journal of Physiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1880654626000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1880654626000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:03:19Z","timestamp":1783159399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1880654626000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1880654626000259"],"URL":"https:\/\/doi.org\/10.1016\/j.jphyss.2026.100079","relation":{},"ISSN":["1880-6546"],"issn-type":[{"value":"1880-6546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db\/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Physiological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphyss.2026.100079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The Physiological Society of Japan.","name":"copyright","label":"Copyright"}],"article-number":"100079"}}